Meadow Creek Investment Management LLC Sells 5,024 Shares of Walgreens Boots Alliance Inc (NASDAQ:WBA)
Meadow Creek Investment Management LLC reduced its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 4.8% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 100,400 shares of the pharmacy operator’s stock after selling 5,024 shares during the quarter. Meadow Creek Investment Management LLC’s holdings in Walgreens Boots Alliance were worth $5,489,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds have also made changes to their positions in the stock. NEXT Financial Group Inc increased its stake in Walgreens Boots Alliance by 27.8% in the second quarter. NEXT Financial Group Inc now owns 2,663 shares of the pharmacy operator’s stock valued at $145,000 after acquiring an additional 580 shares during the last quarter. First National Bank of South Miami boosted its holdings in shares of Walgreens Boots Alliance by 3.0% in the 2nd quarter. First National Bank of South Miami now owns 10,386 shares of the pharmacy operator’s stock worth $566,000 after purchasing an additional 303 shares in the last quarter. Synovus Financial Corp boosted its holdings in shares of Walgreens Boots Alliance by 3.6% in the 2nd quarter. Synovus Financial Corp now owns 16,177 shares of the pharmacy operator’s stock worth $883,000 after purchasing an additional 555 shares in the last quarter. H D Vest Advisory Services bought a new position in shares of Walgreens Boots Alliance during the 2nd quarter valued at about $236,000. Finally, Cornerstone Advisors Inc. raised its holdings in shares of Walgreens Boots Alliance by 131.6% during the 2nd quarter. Cornerstone Advisors Inc. now owns 894 shares of the pharmacy operator’s stock valued at $49,000 after buying an additional 508 shares in the last quarter. Institutional investors own 59.80% of the company’s stock.
WBA traded up $0.35 during trading on Wednesday, hitting $57.23. 301,589 shares of the stock traded hands, compared to its average volume of 4,385,283. The firm has a market capitalization of $50.21 billion, a P/E ratio of 9.54, a price-to-earnings-growth ratio of 1.39 and a beta of 0.88. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.76 and a quick ratio of 0.37. The firm has a 50-day moving average of $52.26 and a 200 day moving average of $55.21. Walgreens Boots Alliance Inc has a 12-month low of $49.03 and a 12-month high of $86.31.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 12th. Investors of record on Tuesday, August 20th will be paid a $0.458 dividend. The ex-dividend date of this dividend is Monday, August 19th. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.44. This represents a $1.83 annualized dividend and a dividend yield of 3.20%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 30.40%.
In other news, CAO Marco Patrick Anthony Pagni sold 215,323 shares of Walgreens Boots Alliance stock in a transaction that occurred on Wednesday, August 14th. The stock was sold at an average price of $50.48, for a total value of $10,869,505.04. Following the sale, the chief accounting officer now directly owns 357,851 shares in the company, valued at approximately $18,064,318.48. The sale was disclosed in a filing with the SEC, which is available through this link. 15.73% of the stock is owned by company insiders.
A number of research firms recently weighed in on WBA. Bank of America dropped their target price on Walgreens Boots Alliance from $53.00 to $51.00 and set an “underperform” rating for the company in a research report on Monday, June 3rd. BidaskClub upgraded shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Wednesday. JPMorgan Chase & Co. decreased their price target on shares of Walgreens Boots Alliance from $74.00 to $73.00 and set an “overweight” rating on the stock in a research note on Friday, June 28th. Zacks Investment Research lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and set a $53.00 price objective for the company. in a report on Monday, June 10th. Finally, ValuEngine raised shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Friday, June 28th. Six research analysts have rated the stock with a sell rating, ten have given a hold rating and four have given a buy rating to the stock. Walgreens Boots Alliance presently has a consensus rating of “Hold” and an average price target of $63.65.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.